Onconova Therapeutics Inc... (ONTX)

AI Score

Unlock

1.00

0.00 (0.00%)

At close: Apr 02, 2024, 8:00 PM

Onconova Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Cash & Equivalents	16.39M	20.82M	25.24M	29.73M	34.22M	38.76M	42.61M	46.53M	50.77M	55.07M	59.38M	43.71M	48.01M	19.02M	24.2M	27.23M	31.04M	22.73M	4.82M	5.88M	10.4M	16.97M	22.38M	29.54M	7.26M	4.02M	7.6M	14.99M	15.39M	21.4M	25.78M	12.82M	16.84M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	1K	1K	1K	1K	1K	1K	1K	10K	10K	10K	12K	140K	150K	150K	150K	150K	150K	150K	150K	150K	150K	149K	12K	12K	12K	12K	12K	12K	12K	12K	12K	12K	12K
Receivables	18K	18K	18K	17K	17K	29K	28K	28K	27K	28K	29K	27K	38K	37K	46K	41K	45K	98K	23K	1.71M	35K	35K	24K	72K	477K	59K	57K	233K	126K	31K	904K	2.15M	1.37M
Inventory	1.48M	1.42M	1.45M	98K	734K	97K	807K	31K	277K	297K	n/a	n/a	394K	542K	n/a	408K	573K	510K	868K	n/a	n/a	692K	593K	462K	n/a	743K	n/a	n/a	794K	1.56M	1.12M	n/a	n/a
Other Current Assets	263K	401K	303K	704K	68K	561K	303K	1.47M	306K	35K	529K	457K	213K	180K	757K	312K	222K	140K	89K	833K	759K	68K	103K	83K	814K	77K	1.05M	761K	104K	73K	97K	1.02M	1.2M
Total Current Assets	18.15M	22.66M	27.01M	30.45M	35.04M	39.35M	43.75M	48.03M	51.38M	55.43M	59.94M	44.19M	48.65M	19.78M	25M	27.99M	31.88M	23.47M	5.8M	8.43M	11.19M	17.77M	23.1M	30.16M	8.55M	4.9M	8.71M	15.98M	16.41M	23.07M	27.9M	15.99M	19.41M
Property-Plant & Equipment	18K	22K	26K	17K	21K	24K	28K	31K	35K	38K	42K	45K	49K	52K	56K	60K	47K	50K	54K	1K	1K	9K	20K	34K	48K	64K	83K	105K	129K	152K	176K	200K	224K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	19K	23K	27K	18K	22K	25K	29K	41K	45K	48K	54K	185K	199K	202K	206K	210K	197K	200K	204K	151K	151K	158K	32K	46K	60K	76K	95K	117K	141K	164K	188K	212K	236K
Total Assets	18.17M	22.68M	27.04M	30.47M	35.06M	39.37M	43.78M	48.07M	51.42M	55.48M	59.99M	44.38M	48.85M	19.99M	25.21M	28.2M	32.07M	23.67M	6M	8.58M	11.34M	17.92M	23.14M	30.2M	8.62M	4.98M	8.8M	16.1M	16.55M	23.23M	28.09M	16.2M	19.64M
Account Payables	6.57M	5.62M	6.15M	5.07M	4.9M	3.86M	3.76M	3M	3.12M	2.76M	4.05M	4.29M	3.99M	4.83M	5.72M	5.15M	4.18M	4.27M	4.52M	4.75M	4.33M	4.04M	4.26M	5.95M	7.03M	6.19M	5.44M	5.68M	5.41M	5.32M	4.07M	2.8M	3.3M
Deferred Revenue	226K	226K	226K	226K	226K	226K	226K	226K	226K	226K	226K	226K	226K	226K	226K	226K	226K	226K	226K	226K	226K	226K	455K	455K	455K	455K	455K	455K	455K	455K	455K	455K	455K
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.83M	4.16M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4.18M	4.24M	n/a	n/a
Other Current Liabilities	2.63M	3.38M	3.3M	3.37M	4.1M	3.96M	3.35M	3.23M	2.6M	3.13M	2.75M	2.98M	3.11M	4.96M	3.34M	3.38M	2.5M	3.79M	3.45M	3.77M	14K	13K	3.49M	3.57M	3.06M	3.33M	3.1M	3.73M	4.02M	198K	243K	5.84M	3.89M
Total Current Liabilities	9.42M	9.22M	9.67M	8.67M	9.22M	8.05M	7.34M	6.46M	5.95M	6.12M	7.03M	7.5M	7.33M	10.02M	9.29M	8.75M	6.91M	8.29M	8.2M	8.75M	8.41M	8.44M	8.21M	9.98M	10.55M	9.98M	8.99M	9.86M	9.88M	10.16M	9.01M	9.1M	7.64M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	530K	957K	321K	176K	232K	176K	113K	96K	571K	603K	176K	319K	448K	961K	1.77M	1.69M	1.48M	4.95M	3.4M	4.41M	287K	295K
Total Long-Term Liabilities	2.73M	2.79M	2.85M	2.9M	2.96M	3.02M	3.07M	3.13M	3.19M	3.24M	3.3M	3.89M	4.37M	3.79M	3.7M	3.81M	3.81M	3.81M	3.85M	4.38M	4.47M	4.1M	4.07M	4.31M	4.94M	5.86M	5.89M	5.79M	9.38M	7.95M	9.06M	5.06M	5.18M
Total Liabilities	12.16M	12.01M	12.52M	11.57M	12.19M	11.06M	10.41M	9.59M	9.13M	9.36M	10.32M	11.38M	11.7M	13.81M	12.99M	12.57M	10.72M	12.1M	12.05M	13.13M	12.88M	12.54M	12.28M	14.29M	15.49M	15.84M	14.88M	15.66M	19.27M	18.11M	18.07M	14.15M	12.82M
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	211K	210K	210K	210K	210K	209K	209K	209K	209K	209K	209K	158K	2.37M	1.86M	1.84M	1.74M	1.67M	1.11M	82K	60K	59K	57K	57K	851K	194K	108K	99K	99K	68K	68K	68K	27K	274K
Retained Earnings	-487.61M	-482.63M	-478.45M	-473.71M	-469.46M	-463.68M	-458.26M	-452.87M	-448.84M	-444.72M	-440.95M	-437.5M	-433.27M	-428.56M	-422.13M	-415.89M	-408.49M	-403.4M	-397.65M	-393.06M	-389.5M	-381.9M	-376.25M	-370.9M	-367.41M	-362.32M	-356.11M	-349.15M	-346.56M	-338.22M	-332.78M	-331.18M	-325.8M
Comprehensive Income	-30K	-23K	-30K	-28K	-27K	-33K	-61K	-41K	-21K	-14K	-6K	2K	-2K	14K	-2K	-17K	-24K	-18K	-27K	-14K	-18K	-12K	-7K	-5K	11K	3K	-1K	-10K	-26K	-31K	-17K	-19K	-16K
Shareholders Equity	6.01M	10.67M	14.52M	18.9M	22.88M	28.31M	33.37M	38.48M	42.29M	46.12M	49.67M	32.99M	37.15M	6.17M	12.21M	15.63M	21.35M	11.57M	-6.04M	-4.55M	-1.54M	5.39M	10.86M	15.91M	-7.71M	-11.69M	-6.91M	-388K	-3.54M	4.3M	9.19M	1.22M	5.99M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a